Informasjon

Urinsyregikt, podagra

Urinsyregikt er en betennelse i ledd som fører til at leddet blir smertefullt, varmt, rødt og hovent.

Vil du vite mer?

Psoriasis
NSAIDs
Puriner
Urinsyregikt - for helsepersonell

Dette dokumentet er basert på det profesjonelle dokumentet "Urinsyregikt". Referanselisten for dette dokumentet vises nedenfor.

Hui M, Carr A, Cameron S, et al. The British Society for Rheumatology Guideline for the management of gout. Rheumatology 2017; 56: e1–e20. doi.org
Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76: 801-8. pmid: 17910294 PubMed
Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42. pmid: 12087559 PubMed
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011;63:3136-3141. pmid: 21800283 PubMed
Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988;41:237-242. pmid: 3339376 PubMed
Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005; 17: 341-5. pmid: 15838248 PubMed
Kamienski M. Gout: not just for the rich and famous! Everyman's disease. Orthop Nurs 2003; 22: 16-20. pmid: 12640948 PubMed
Weaver AL. Epidemiology of gout. Cleve Clin J Med 2008;75(suppl 5):S9-S12. pmid: 18819329 PubMed
Kim KY, Schumacher HR, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-1616. pmid: 12860487 PubMed
Underwood M. Diagnosis and management of gout. BMJ 2006; 332: 1315-9. PubMed
Rothschild BM. Gout and pseudogout. Medscape, last updated Jan 17, 2018. emedicine.medscape.com
Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000;11:974-979. pmid: 10770978 PubMed
Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol 2002;14:281-286. pmid: 11981327 PubMed
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G . Alcohol intake and risk of incident gout in men: a prospective study . Lancet 2004; 363: 1277-81. pmid: 15094272 PubMed
Williams PT. Effects of diet, physical activity and performance, and body weight on incident gout in ostensible healthy, vigorously active men. Am J Clin Nutr 2008; 87: 1480-7. pmid: 18469274 PubMed
Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000;27:1501-1505. pmid: 10852278 PubMed
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093-1103. pmid: 15014182 PubMed
Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336: 309-12. pmid: 18244959 PubMed
Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010; 304: 2270-8. pmid: 21068145 PubMed
Sivera F, Andres M, Carmona L, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2013. pmid: 23868909 PubMed
Neogi T, Jansen TLTA, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015;74:1789–98. pmid: 24671771 PubMed
Uhlig T, Eskild T, Hammer HB. Urinsyregikt – nytt innen diagnostikk og behandling. Tidsskr Nor Lægeforen 2016; 136: 1804-7. doi:10.4045/tidsskr.16.0147 DOI
Dalbeth N, Kalluru R, Aati O, et al. Tendon involvment in the feet of patients with gout: a dual-energy CT study. Ann Rheum Dis 2013; 72: 1545-8. pmid: 23334212 PubMed
Terkeltaub RA. Gout. N Engl J Med 2003; 349: 1647-55. pmid: 14573737 PubMed
Uhlig T. Urinsyregikt og hyperurikemi - skal begge deler behandles?. Tidsskr Nor Lægeforen 2003; 123: 2878-80. PubMed
Bongartz T, Glazebrook KN, Kavros SJ, et al. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis 2014. pmid: 24671771 PubMed
Ogdie A, Taylor WJ, Neogi T et al. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard. Arthritis Rheumatol 2017; 69(2): 429-38. pmid:27748084 PubMed
van Durme CM, Wechalekar MD, Buchbinder R, et al. Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev 2014; 9: CD010120. pmid:25225849 PubMed
Vinik O, Wechalekar MD, Falzon L, et al. Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review. J Rheumatol Suppl. 2014;92:70-4. pmid: 23024028 PubMed
Johnson RJ, Rideout BA. Uric acid and diet - insights into the epidemic of cardiovascular disease. N Engl J Med 2004; 350: 1071-2. pmid: 15014177 PubMed
Khanna D, Fitzgerald JD, Khanna PP, et al; American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012;64:1431-1446. PubMed
Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG). British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007;46:1372-1374. PubMed
Choi KH, Gao X, Curhan G. Vitamin C intake and the risk of gout in men. Arch Intern Med 2009; 169: 502-7. PubMed
Schlesinger N, Detry MA, Holland BK, et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002;29:331-334. PubMed
Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2016. PMID: 27457514 PubMed
Neoqi T, Chen C, Niu J et al. Alcohol quantity and type on risk of recurrent gout attacks: An internet-based case-crossover study. Am J Med, published online 21 January 2014. pmid: 24440541 PubMed
Harris M, Bryant LR, Danaher P, Alloway J. Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis. J Rheumatol 2000; 27: 2873. pmid:11128679 PubMed
Zhang S, Zhang Y, Liu P, et al. Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis. Clin Rheumatol. 2016 Jan;35(1):151-8. Epub 2015 Jun 24. pmid: 26099603 PubMed
Terkeltaub R, Furst DE, Bennet K, et al. Low dose (1,8 mg) vs high dose (4,8 mg) oral colchicine regimens in patients with acute gout flare in a large, multicenter, randomized, double-blind, placeo-controlled, parallell group study. Arthritis Rheum 2008; 58: 879. PubMed
van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D. Colchicine for acute gout. Cochrane Database Syst Rev 2014; 8: CD006190. pmid:25123076 PubMed
Billy CA;Lim RT;Ruospo M;Palmer SC;Strippoli GFM. Corticosteroid or Nonsteroidal Antiinflammatory Drugs for the Treatment of Acute Gout: A Systematic Review of Randomized Controlled Trials. J Rheumatol. 2017 Aug 1. pii: jrheum.170137. (Review) PMID: 28765243 PubMed
Rainer TH, Cheng CH, Janssens HJ, et al. Oral prednisolone in the treatment of acute gout: A pragmatic, multicenter, double-blind, randomized trial. Ann Intern Med 2016. pmid: 26903390 PubMed
Janssens HJEM, Janssen M, van de Lisdonk EH et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet 2008; 371: 1854-60. PubMed
Zhang YK, Yang H, Zhang JY, et al. Comparison of intramuscular compound betamethasone and oral diclofenac sodium in the treatment of acute attacks of gout. Int J Clin Pract. 2014 Jan 29. pmid: 24472084 PubMed
Dalbeth N, Merriman TR, Stamp LK.Gout.Lancet. 2016 Oct 22;388(10055):2039-2052. Epub 2016 Apr 21.PMID:27112094. PubMed
Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004; 50: 2400-14. PubMed
Taylor TH, Mecchella JN, Larson RJ et al. Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 2012; 125: 1126-34. pmid:23098865 PubMed
Kiltz U, Smolen J, Bardin T, et al. Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis 2016. pmid:27658678 PubMed
Seth R, Kydd AS, Buchbinder R, et al. Allopurinol for chronic gout. Cochrane Database Syst Rev. 2014 Oct 14;10. pmid: 25314636 PubMed
Reinders MK, Haagsma C, Jansen TL et al.: A randomised controlled trial on the efficacy and tolerability with dose-escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout. Ann Rheum Dis 2008; Jul 16 (Epub ahead of print). pmid: 18633127 PubMed
Moreland LW. Febuxostat - treatment for hyperuricemia and gout?. N Engl J Med 2005; 353: 2205-7. PubMed
Stamp LK, Taylor WJ, Jones PB et al. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol. Arthritis Rheum 2012; 64: 2529-36. PubMed
Feig DI, Soletsky B, Johnson RJ. Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial. JAMA 2008; 300: 924-32. PubMed
Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum 2005; 52: 916-23. PubMed
Takano Y, Hase-Aoki K, Horiuchi H, et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sci 2005; 76: 1835-47. PubMed
Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-61. pmid: 16339094 PubMed
Sundy JS, Baraf HS, Yood RA, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011; 306: 711-20. pmid:21846852 PubMed
Arellano F, Sacristán JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993; 27: 337-43. PubMed
Lim SY, Lu N, Choi HK. Septic arthritis in gout patients: a population-based cohort study. Rheumatology (Oxford) 2015; 54: 2095-9. PMID: 26170377 PubMed
Hong J-Y, Lan T-Y, Tang G-J, et al. Gout and the risk of dementia. Arthritis Res Ther 2015;17: 139. PMID: 26018424. PubMed
Calberg MJ, Kjøller E. Patofysiologiske mekanismer bag urats prognostiske betydning ved kardiovaskulær sygdom. Ugeskr Læger 2005; 167: 3771-4. PubMed
Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005; 165: 742-8. PubMed
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971 - 1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404 - 10. pmid: 10815083 PubMed
Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000; 36: 1072 - 8. PubMed
Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900. PubMed
Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH; for the MRFIT Research Group. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008; 168: 1104-10. PubMed
Chen J-H, Lan J-L, Cheng C-F, et al. Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study. J Rheumatol 2015; 42: 1694-1701. pmid: 26077411 PubMed
Palmer TM, Nordestgaard BG, Benn M, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ 2013; 347: f4262. pmid: 23869090 PubMed
Khanna D, Khanna PP, Fitzgerald JD, et al; American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012;64:1447-1461. PubMed

Meld deg på nyhetsbrev

Er du helsepersonell?

Ved å oppgi dette kan du få bedre tilpasset innhold om du har formell helsefaglig kompetanse

Annonsørinnhold

Annonsørinnhold fra Amgen

Høyt kolesterol? Dette må du vite

Høyt kolesterol er en av de viktigste risikofaktorene for å utvikle hjertesykdom. Allikevel har 8 av 10 middelaldrende menn og 6 av 10 middelaldrende kvinner kolesterolnivåer over anbefalt verdi.(1) Finn ut hva konsekvensene kan være – og om du kan ha arvelig høyt kolesterol.

Mest lest i dag

Barn

Urinsyregikt, podagra

Hopp til innhold

Vil du vite mer?

Er du helsepersonell?

Annonsørinnhold

Høyt kolesterol? Dette må du vite

Mest lest i dag

Asperger syndrom

Omgangssyke, tarminfeksjon

Skjelvinger - essensiell tremor

Urinsyregikt, podagra

Hopp til innhold

Vil du vite mer?

Er du helsepersonell?

Andre leste også dette

Akuttbehandling av urinsyregikt

Kirsebær mot urinsyregikt

Purin-innhold i matvarer

Annonsørinnhold

Høyt kolesterol? Dette må du vite

Mest lest i dag

Asperger syndrom

Omgangssyke, tarminfeksjon

Skjelvinger - essensiell tremor